People in Biological Technology

Video: New Way RA(TM) Talk Show Premieres Online for People Living With Rheumatoid Arthritis (RA)

HORSHAM, Pa., July 29 /PRNewswire/ -- New Way RA (TM), a new online talk show hosted by award-winning journalist and anchor of Inside Edition, Deborah Norville, premieres today at www.NewWayRA.com . To view the Multimedia News Release, go to: http://www.prnewswire.com/...

Patton Medical Devices Partners With Unomedical to Develop and Market the i-port Advance(TM) Injection Port for People Taking Multiple Daily Injections

AUSTIN, Texas, July 27 /PRNewswire/ -- Patton Medical Devices, manufacturer of the i-port(R) and a leader of injection port therapy, announced today that they have entered into a partnership agreement with Unomedical, a leading manufacturer of single use medical devices used in th...

MEDS World, LLC Provides Multiple Environments with Designed Solutions - Wherever People Congregate, MEDS Odor Elimination Solutions Offer Eco-Friendly, Odor-Free Air

In 2008, Bruce Hecht and Chase Walker formed MEDS World, LLC, launching innovative odor elimination, exterior plastic trim and headlight restoration products to the Automotive, RV and Marine industries. Bruce and Chase have combined over fifty years of management experiences, in a myriad of indus...

Kendle Senior Scientist Edward Sellers, MD, PhD, Named One of Nine 'Notable People in R&D'

Industry publication R&D Directions honors Dr. Sellers' pioneering work in human abuse liability studies CINCINNATI, March 26 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL ), a leading, global full-service clinical research organization, today announced Edward Sellers, MD, PhD, Senior ...

Video: Experts Unite to Help People Manage Spring Nasal Allergy Sneezin'

Simple Steps Can Make a Big Difference in Managing Indoor and Outdoor Allergies ATLANTA and BRIDGEWATER, N.J., March 2 /PRNewswire-FirstCall/ -- As this year's spring nasal allergy season quickly approaches, people living with nasal allergies should take steps to manage their symptoms and war...

MyHeritage And Family Tree DNA Partner To Help People Trace Family History Using DNA

MyHeritage, one of the world's most popular family Web sites, today announced a partnership with FamilyTreeDNA, the company that pioneered DNA testing for genealogic research. In addition to MyHeritage's innovative Smart Matching and Research technologies, members can now also use information con...

LF Elimination Program Treats Over Half Billion People and Protects Millions More From Debilitating Disease

- Study demonstrates 'Best buy in public health' LONDON, Oct. 7 /PRNewswire-FirstCall/ -- A study published today confirms that in the ten years since its initiation, the international effort to eliminate lymphatic filariasis (LF) has made unprecedented strides towards ridding the ...

Video: New, Advanced Therapy Program Helps People Who Stutter Acquire Fluent Speech

Hollins Communications Research Institute Forges New Ground in the Treatment of Stuttering ROANOKE, Va., July 15 /PRNewswire/ -- Scientists at Hollins Communications Research Institute (HCRI), a non-profit research and clinical center ( http://www.stuttering.org ) s...

American Telugu Association's Convention Attracts Over 10,000 People in the U.S.

The 10th American Telugu Association (ATA) Conference & Youth Convention, an upcoming mega event, being held from July 3 to July 5, 2008 in Newark, New Jersey, is all set to receive more than 10,000 people from NRI Telugu community. Newark, NJ (PRWEB) June 30, 2008 ...

Growing old together: Yeast, worms and people may age by similar mechanisms

Thursday, March 13, 2008 A study published online today in Genome Research ( www.genome.org ) provides new insight into the evolutionary conservation of the genes and pathways associated with aging. This report describes the identification of conserved aging-related genes in simple model organ...

Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes

Study Shows Statin and Antioxidant Therapy to be Superior to Statins Alone in Decreasing Cardiovascular Events in Diabetics with Haptoglobin 2-2 Genotype MONTVALE, N.J., March 5 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (Amex: SYI ) announces the p...

'Move to AMITIZA' Advertising Campaign Underscores the Power of Not Letting Chronic Constipation Slow People Down

Ads Creatively Depict the Predictable Relief Provided by the Only Commercially Available Prescription Treatment for Chronic Idiopathic Constipation in Adults DEERFIELD, Ill., Nov. 6 /PRNewswire/ -- Takeda Pharmaceuticals North America, Inc. and Sucampo Pharmaceutica...

Video: New Survey Finds Technology Plays a Critical Role in Lives of People with Multiple Sclerosis, Yet Many Are Not Using it to Overcome Disease-Related Challenges

- Affordable, Easy-to-Use Accessible Technology is Within Reach for People with MS - DALLAS, Oct. 26 /PRNewswire/ -- According to a new survey released this week in conjunction with the National MS Society's National Conference, many people living with multiple scl...

International Survey Shows People Over Forty Ignore Risk of Blindness

LONDON, October 2 /PRNewswire/ -- - Global Advocacy Groups Launch Joint Effort to Preserve Eyesight of Millions At-Risk for Glaucoma Results of a new international survey reveal that eye exams are being ignored by many aged over 40. Only two fifths of respondents had visited an eye specialis...

The International Diabetes Federation (IDF) Recommends Tighter Control of Blood Glucose Levels After Meals in People With Diabetes

AMSTERDAM, September 19 /PRNewswire/ -- - IDF Launches New Guideline for the Management of Postmeal Glucose IDF today issued the new global guideline for diabetes care which includes the management of postmeal glucose.(1) The guideline emphasizes that people with diabetes should have their b...

Advanced Cell Technology's Dr. Robert Lanza Makes List of '100 Most Inspiring People in the Life-Sciences Industry'

PharmaVOICE magazine cites Dr. Lanza for 'Courage Under Fire' WORCESTER, Mass., Aug. 21 /PRNewswire-FirstCall/ -- Advanced Cell Technology, Inc. (OTC Bulletin Board: ACTC) is proud to announced that Dr. Robert Lanza, the company's Vice President of Research and Scientific Development, has...

Analog people in the digital revolution

Youve heard the drumbeat about IT project failure rates. Youve probably heard mention of all the usual suspects like the lack of sponsor support, poor requirements and scope definition, lack of business relevance or bad communication. What might not be so apparent in all of this hand wringing is th...

Analog people in the Digital Revolution, part II

In my previous column, I started a discussion about what people are good for in the digital revolution. Theres a lot of blah, blah, blah out there about the complexity of current business and technical environments and the need for better judgment, greater flexibility, improved communication and mo...

Got Game makes big claims; can 90 million people think the same?

Got Game (2004, Harvard Business School Press) takes a detailed look at how video games have affected the people who grew up playing them. Authors John C. Beck and Mitchell Wade compiled personal interviews and surveys to give business managers a lesson on how to handle the increasing nu...

Berbee puts people first to deliver high-quality technology

Madison, Wis. - When Berbee Information Networks was founded in 1993, founder James Berbee launched the company with two guiding principles: high quality customer service and technology. Now in its twelfth year, Berbee has channeled these philosophies to create one of the largest and most ...

Can tech people be business leaders? Upcoming seminar may have the answer

When Cay Villars worked in marketing for the biotechnology sector, she began to notice a certain pattern: Scientists with a good idea for a new product could find the business world to be a much different place than academia, with a different set of skills required to succeed. "Along the way, I ...

Two-week notices: People are still concerned

Giving two-weeks' notice when leaving a job is becoming more and more a rare option rather than a must-do. From articles written over a year ago, I'm still getting feedback about people giving two-weeks' notice and then being told to leave that day. Many believe that two-week notices no longer ar...

Age of empowered individuals: People power behind robust computing

Editor's Note: This is the text of Chris Shipley's keynote speech given to open the recent DEMO 2007 Conference in Palm Desert, Calif. I shouldn't be surprised by the energy in this room today, and neither should you. You are at the very center of an exciting shift in the information technol...

Power for the people

We pull the plugs, cut the cords, and can the cables as we move deeper into our highly mobile, always-connected, convenience-centered lives. But for all the freedom and mobility, we are nowhere without energy to power the laptops, mobile phones, PDAs, BlackBerries and the like. That fact alone ha...

Technology helps but the best way to reduce Sarbox cost is with people

The heartbeat of strong controls is clearly in the hands of people. While the movement to automate controls has appropriately gained momentum in an effort to reduce testing efforts and maximize operating effectiveness, the majority of entity-wide controls rely upon people. Investing in your pe...

Prix Galien USA Announces 2009 Final Candidates

...September 30. Candidates for the 2009 program provide relief to millions of people living with chronic diseases including cardiovascular disease and diabetes and treatments for people living with cancer and HIV/AIDS. The 2009 Prix Galien USA ceremony will aga...

Onyx Pharmaceuticals Announces Pricing of Concurrent Offerings of Four Million Shares of Common Stock and $200 Million Principal Amount of Convertible Senior Notes

... prospectus. About Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer. The company, in collaboration with Bayer HealthCare Pharmaceuticals Inc., is developing and marketing Nexavar(R) (sorafenib) tablets, a ...

GeoVax Labs, Inc. Provides Clinical Studies Update

...ials - Planning for Phase 1 To help serve those people who are already infected with HIV, the Company is ...x AIDS vaccines are designed for use in uninfected people to prevent Acquired Immunodeficiency Disease (AIDS...lso may be effective as therapeutics (treatment of people already infected with HIV). GeoVax's core A...

Ceregene Receives Additional Grant From Michael J. Fox Foundation to Expand Long-Term Testing of CERE-120 Patients

...hat was announced in June 2007. About Parkinson's Disease Parkinson's disease is a progressive movement disorder that affects a million people in the United States. Its main symptoms, stiffness, tremors and slowed movements and gait, are caused by a loss of dopamine-containing nerve cells in ...

Next Safety Releases Advanced Respirator for Infectious Diseases

... JEFFERSON, N.C., Aug. 5 /PRNewswire/ -- Next Safety, Inc. (NSI) announces advanced respirators that give people more confidence to go to work in a pandemic environment. Next Safety is releasing for sale to the public respirator products the company developed for...

Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update

...ceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative oncology products to impact the lives of people with cancer. Picoplatin, the Company's lead platform product candidate, is a new generation platinum chemotherapy. To date, clinical studies suggest ...

Webcast of QIAGEN N.V.'s (Nasdaq: QGEN) Second Quarter 2009 Financial Results Call Set for August 11

... panel includes the only FDA-approved test for human papillomavirus (HPV), the primary cause of cervical cancer. QIAGEN employs more than 3,100 people in over 30 locations worldwide. Further information about QIAGEN can be found at www.qiagen.com . (Minimum Requirements to listen to broadca...

Eiger BioPharmaceuticals Acquires Exclusive License to Novel Hepatitis C Virus (HCV) Technology From Stanford University

... future cocktails for HCV therapy." About Hepatitis C Virus Infections from HCV have reached pandemic proportions, affecting over 150 million people worldwide. According to the Centers for Disease Control (CDC), 3.9 million Americans have been exposed to HCV, resulting in 2.7 million cases of chron...

Sanofi-aventis U.S. Introduces BenzaClin(R) Carekit

... BRIDGEWATER, N.J., Aug. 4 /PRNewswire-FirstCall/ -- With acne being one of the most common skin diseases affecting nearly 80 percent of people between the ages of 12 and 24, Dermik Laboratories, a business of sanofi-aventis U.S., announced today the availability of the BenzaClin(R) (clindamyc...

Palatin Technologies, Inc. Receives U.S. Patent Allowance for Heart Failure Drug Candidate

... drug candidate with improved pharmacokinetic and pharmacodynamic properties. About Heart Failure Heart failure affects over 5.7 million people in the United States, with 670,000 new cases diagnosed each year. Despite the treatment of heart failure with multiple drugs, the prognosis remains po...

Biotech Hot in July Driven by Positive Drug Data and Acquisitions

...Orexigen Therapeutics shares jumped 54 percent in July after revealing that Contrave, a longer lasting form of two generic diet drug compounds, helped people lose weight in all three of its major clinical trials. That should clear the way for the San Diego biotech to file for approval to market the drug wit...

National Institutes of Health Chooses Web of Science(R) to Power electronic Scientific Portfolio Assistant (eSPA)

...trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 50,000 people in 93 countries. For more information, go to thomsonreuters.com . ...

Five Questions About Protopic (tacrolimus) Ointment

...s S h ould Kno w About Protopic Ointment The safety of using Protopic Ointment for a long period of time is not known. A very small number of people who have used Protopic Ointment have had cancer (for example, skin or lymphoma). However, a link with Protopic Ointment has not been shown. Because ...

Micromet Receives European Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia with BiTE Antibody Blinatumomab

...intended for the diagnosis, prevention or treatment of life-threatening or chronically debilitating conditions that affect no more than five in 10,000 people in the European Union, or are medicines which, for economic reasons, would be unlikely to be developed without incentives. The aim of the EU le...

Cardinal Health Completes Biotech Acquisition

...he largest distributors of pharmaceuticals and medical supplies worldwide. Ranked No. 18 on the Fortune 500, Cardinal Health employs more than 40,000 people on five continents. More information about the company may be found at www.cardinalhealth.com . ...